148 related articles for article (PubMed ID: 23113628)
1. Optimal diabetes care outcomes following face-to-face medication therapy management services.
Brummel AR; Soliman AM; Carlson AM; de Oliveira DR
Popul Health Manag; 2013 Feb; 16(1):28-34. PubMed ID: 23113628
[TBL] [Abstract][Full Text] [Related]
2. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
[TBL] [Abstract][Full Text] [Related]
3. Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25491911
[TBL] [Abstract][Full Text] [Related]
4. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes.
Fox D; Ried LD; Klein GE; Myers W; Foli K
J Am Pharm Assoc (2003); 2009; 49(2):192-9. PubMed ID: 19289345
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a hypertension medication therapy management program in patients with diabetes.
Planas LG; Crosby KM; Mitchell KD; Farmer KC
J Am Pharm Assoc (2003); 2009; 49(2):164-70. PubMed ID: 19289342
[TBL] [Abstract][Full Text] [Related]
6. Patient characteristics predicting the frequency of medication therapy management visits for patients with diabetes.
Soliman AM; Carlson AM; MacLehose RF; Brummel AR; Schommer JC
Clin Ther; 2013 Apr; 35(4):534-40. PubMed ID: 23541131
[TBL] [Abstract][Full Text] [Related]
7. Impact on drug cost and use of Medicare part D of medication therapy management services delivered in 2007.
Winston S; Lin YS
J Am Pharm Assoc (2003); 2009; 49(6):813-20. PubMed ID: 19858047
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
9. Patient satisfaction with a pharmacist-provided telephone medication therapy management program.
Moczygemba LR; Barner JC; Brown CM; Lawson KA; Gabrillo ER; Godley P; Johnsrud M
Res Social Adm Pharm; 2010 Jun; 6(2):143-54. PubMed ID: 20511113
[TBL] [Abstract][Full Text] [Related]
10. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
[TBL] [Abstract][Full Text] [Related]
11. Nontraditional or noncentralized models of diabetes care: medication therapy management services.
Chawla S
J Fam Pract; 2011 Nov; 60(11 Suppl):S12-8. PubMed ID: 22336920
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries.
Welch EK; Delate T; Chester EA; Stubbings T
Ann Pharmacother; 2009 Apr; 43(4):603-10. PubMed ID: 19318600
[TBL] [Abstract][Full Text] [Related]
13. What Patients Know About Services to Help Manage Chronic Diseases and Medications: Findings from Focus Groups on Medication Therapy Management.
Taylor AM; Axon DR; Campbell P; Fair MK; Nelson M; Boesen K; Martin R; Warholak TL
J Manag Care Spec Pharm; 2018 Sep; 24(9):904-910. PubMed ID: 30156456
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an Academic-Community Partnership to Implement MTM Services in Rural Communities to Improve Pharmaceutical Care for Patients with Diabetes and/or Hypertension.
Johnson M; Jastrzab R; Tate J; Johnson K; Hall-Lipsy E; Martin R; Taylor AM; Warholak T
J Manag Care Spec Pharm; 2018 Feb; 24(2):132-141. PubMed ID: 29384026
[TBL] [Abstract][Full Text] [Related]
15. Impact of a Medicare MTM program: evaluating clinical and economic outcomes.
Hui RL; Yamada BD; Spence MM; Jeong EW; Chan J
Am J Manag Care; 2014 Feb; 20(2):e43-51. PubMed ID: 24738554
[TBL] [Abstract][Full Text] [Related]
16. Understanding the landscape of MTM programs for Medicare. Part D: Results from a study for the Centers for Medicare & Medicaid services.
Shoemaker SJ; Hassol A
J Am Pharm Assoc (2003); 2011; 51(4):520-6. PubMed ID: 21752775
[TBL] [Abstract][Full Text] [Related]
17. An online virtual-patient program to teach pharmacists and pharmacy students how to provide diabetes-specific medication therapy management.
Battaglia JN; Kieser MA; Bruskiewitz RH; Pitterle ME; Thorpe JM
Am J Pharm Educ; 2012 Sep; 76(7):131. PubMed ID: 23049103
[TBL] [Abstract][Full Text] [Related]
18. The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta.
Ross LA; Bloodworth LS; Brown MA; Malinowski SS; Crane R; Sutton V; Karimi M; Dove Brown AC; Dobbs T; Hites L
Prev Chronic Dis; 2020 Sep; 17():E108. PubMed ID: 32945767
[TBL] [Abstract][Full Text] [Related]
19. Preparing pharmacists for medication therapy management services: designing lementing pharmacist-run diabetes management program in a community setting.
Pinto SL; Morgan EE
Manag Care Interface; 2007 Jan; 20(1):52-6. PubMed ID: 17310653
[TBL] [Abstract][Full Text] [Related]
20. Variation in Medication Therapy Management Delivery: Implications for Health Care Policy.
Snyder ME; Jaynes HA; Gernant SA; Lantaff WM; Hudmon KS; Doucette WR
J Manag Care Spec Pharm; 2018 Sep; 24(9):896-902. PubMed ID: 30156453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
